News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
571,165 Results
Type
Article (15238)
Company Profile (149)
Press Release (555864)
Multimedia
Podcasts (20)
Webinars (13)
Section
Business (194776)
Career Advice (650)
Deals (29373)
Drug Delivery (36)
Drug Development (61693)
Employer Resources (62)
FDA (11551)
Job Trends (10346)
News (278538)
Policy (21956)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1193)
Accelerated approval (38)
ADA (26)
Adcomms (15)
Allergies (130)
Alliances (38945)
ALS (141)
Alzheimer's disease (1288)
Antibody-drug conjugate (ADC) (383)
Approvals (12247)
Artificial intelligence (484)
ASCO (198)
Autoimmune disease (254)
Automation (36)
Bankruptcy (292)
Belgium (1)
Best Places to Work (8339)
BIO (76)
Biologics (8)
BIOSECURE Act (4)
Biosimilars (151)
BioSpace Insights (52)
Biotechnology (93)
Bladder cancer (145)
Brain cancer (43)
Breast cancer (602)
Cancer (4660)
Cardiovascular disease (295)
Career advice (556)
Career pathing (16)
CAR-T (224)
CDC (10)
CDMO (36)
Celiac Disease (2)
Cell therapy (606)
Cervical cancer (43)
Clinical research (55752)
Collaboration (1635)
Commercialization (4)
Compensation (1533)
Complete response letters (50)
COVID-19 (1164)
CRISPR (77)
C-suite (1032)
Cystic fibrosis (110)
Data (7021)
Decentralized trials (1)
Denatured (12)
Depression (117)
Dermatology (86)
Diabetes (454)
Diagnostics (5256)
Digital health (50)
Diversity (2)
Diversity, equity & inclusion (17)
Drug discovery (238)
Drug pricing (36)
Drug shortages (3)
Duchenne muscular dystrophy (197)
Earnings (85209)
Editorial (12)
Employer branding (9)
Employer resources (60)
Events (100451)
Executive appointments (880)
FDA (14760)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (18)
Frontotemporal dementia (29)
Funding (1197)
Gene editing (149)
Generative AI (28)
Gene therapy (427)
GLP-1 (443)
Government (1816)
Grass and pollen (3)
Guidances (351)
Healthcare (12107)
Hematology (124)
HIV (75)
Huntington's disease (31)
IgA nephropathy (86)
Immunology and inflammation (126)
Immuno-oncology (79)
Indications (191)
Infectious disease (1410)
Inflammatory bowel disease (155)
Inflation Reduction Act (4)
Influenza (110)
Intellectual property (288)
Interviews (94)
IPO (14179)
IRA (5)
Job creations (2393)
Job search strategy (503)
JPM (9)
Kidney cancer (21)
Labor market (15)
Layoffs (145)
Leadership (12)
Legal (5809)
Licensing (19)
Liver cancer (56)
Longevity (25)
Lung cancer (665)
Lymphoma (348)
Machine learning (42)
Management (23)
Manufacturing (753)
Marketing (10)
MASH (150)
Medical affairs (2)
Medical device (10469)
Medtech (10647)
Mergers & acquisitions (16359)
Metabolic disorders (957)
mRNA (85)
Multiple sclerosis (126)
NASH (4)
Netherlands (2)
Neurodegenerative disease (312)
Neuropsychiatric disorders (50)
Neuroscience (2399)
NextGen: Class of 2026 (3991)
Non-profit (1931)
Now hiring (8)
Obesity (331)
Opinion (74)
Ovarian cancer (187)
Pain (206)
Pancreatic cancer (252)
Parkinson's disease (287)
Partnered (18)
Patents (533)
Patient recruitment (621)
Peanut (45)
People (49298)
Peptides (2)
Pharmaceutical (36)
Pharmacy benefit managers (9)
Phase 1 (17542)
Phase 2 (24635)
Phase 3 (17493)
Pipeline (9104)
Policy (75)
Postmarket research (1968)
Preclinical (7489)
Press Release (47)
Prostate cancer (259)
Psychedelics (12)
Radiopharmaceuticals (319)
Rare diseases (734)
Real estate (3891)
Recruiting (27)
Regulatory (18403)
Reports (28)
Research institute (1167)
Resumes & cover letters (89)
Rett syndrome (45)
RNA editing (9)
RSV (55)
Schizophrenia (133)
Series A (198)
Series B (157)
Service/supplier (5)
Sickle cell disease (76)
Spinal muscular atrophy (99)
Sponsored (22)
Startups (2440)
Stomach cancer (8)
Supply chain (73)
Tariffs (18)
The Weekly (8)
Vaccines (527)
Venture capital (39)
Weight loss (138)
Women's health (98)
Worklife (6)
Date
Today (137)
Last 7 days (471)
Last 30 days (1793)
Last 365 days (22830)
2026 (15967)
2025 (22633)
2024 (26652)
2023 (30963)
2022 (39718)
2021 (42921)
2020 (39592)
2019 (30296)
2018 (22892)
2017 (23521)
2016 (22628)
2015 (29243)
2014 (25186)
2013 (21178)
2012 (23270)
2011 (23817)
2010 (22994)
Location
Africa (434)
Alabama (80)
Alaska (3)
Arizona (336)
Arkansas (11)
Asia (27764)
Australia (4199)
California (12946)
Canada (3468)
China (1102)
Colorado (521)
Connecticut (466)
Delaware (269)
Europe (51116)
Florida (1997)
Georgia (413)
Hawaii (4)
Idaho (47)
Illinois (867)
India (82)
Indiana (445)
Iowa (19)
Japan (559)
Kansas (118)
Kentucky (34)
Louisiana (36)
Maine (78)
Maryland (1386)
Massachusetts (8942)
Michigan (347)
Minnesota (662)
Mississippi (4)
Missouri (109)
Montana (22)
Nebraska (17)
Nevada (127)
New Hampshire (68)
New Jersey (3159)
New Mexico (17)
New York (3161)
North Carolina (1492)
North Dakota (6)
Northern California (6500)
Ohio (338)
Oklahoma (20)
Oregon (23)
Pennsylvania (2436)
Puerto Rico (22)
Rhode Island (32)
South America (710)
South Carolina (78)
South Dakota (1)
Southern California (5355)
Tennessee (137)
Texas (2148)
United States (43715)
Utah (385)
Vermont (1)
Virginia (189)
Washington D.C. (46)
Washington State (1004)
West Virginia (1)
Wisconsin (117)
Wyoming (3)
571,165 Results for "international isotopes inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
FDA rejects ITM Isotope’s radiopharma therapy over manufacturing issues
ITM Isotope Technologies plans on resubmitting its advanced cancer radiopharma therapy to the FDA after addressing the agency’s concerns.
August 11, 2026
·
1 min read
·
Gabrielle Masson
Insights
The Radiotherapeutics Moment: How Isotopes are Changing Cancer Treatment
In this episode of Denatured, you’ll listen to Dr. Marc Hedrick, President and CEO of Plus Therapeutics and Dr. Phil Kantoff, CEO & Co-founder of Convergent Therapeutics. They discuss breakthroughs like alpha-emitting isotopes, supply chain solutions and why radiotherapeutics is biotech’s next big frontier.
April 2, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
Thermo Fisher Scientific Launches First Orbitrap Mass Spectrometers for Isotope Ratio Analysis, Enabling More Labs to Decode the Story Behind a Sample
August 25, 2026
·
7 min read
Press Releases
TerraPower Isotopes Breaks Ground on World’s Largest Actinium-225 Manufacturing Facility in Philadelphia
May 7, 2026
·
4 min read
Business
International Isotopes Inc. Announces Fiscal Results for Fiscal Year 2023
International Isotopes Inc. announces its financial results for the twelve-month periods ended December 31, 2023.
April 1, 2024
·
6 min read
Press Releases
Cambridge Isotope Laboratories Announces Eurisotop as Direct Supplier of Environmental Standards in Europe
April 1, 2026
·
2 min read
Press Releases
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India
October 28, 2025
·
3 min read
Press Releases
SpectronRx Secures $85 Million to Expand Medical Isotope Production, CDMO and CMO Capabilities at Grissom Aeroplex Campus
34-acre campus supports 200,000 square feet of GMP manufacturing, with long-term expansion capacity exceeding one million square feet
April 2, 2026
·
1 min read
Business
International Isotopes Inc. Announces Fiscal Results for the Third Quarter and First Nine Months of 2023
International Isotopes Inc. announces its financial results for the three- and nine-month periods ended September 30, 2023.
November 14, 2023
·
6 min read
Press Releases
Cambridge Isotope Laboratories, Inc. Unveils ISOAPI-D - a New Standard in Deuterated Reagents for Pharmaceutical Innovation - at CPhI Frankfurt 2025
October 28, 2025
·
3 min read
1 of 57,117
Next
